Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
David Michael Johnson Insider Profile
11 Followers
David Michael Johnson, Director at Zentalis Pharmaceuticals, holds 144.39K shares in Zentalis Pharmaceuticals (Ticker: ZNTL), holds 425.34K shares in Aura Biosciences Inc (Ticker: AURA). Most recently, David Michael Johnson Bought ― shares of Zentalis Pharmaceuticals on Nov 13, 2023 for an estimated value of 167.79K.
David Michael Johnson Zentalis Pharmaceuticals (ZNTL)Director
Zentalis Pharmaceuticals (ZNTL)
Director
Ranked #63,180 out of 98,743 Corporate Insiders
Profitable Transactions
2 out of 7 Profitable Transactions
Average Return
-6.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that David Michael Johnson holds in companies
Most Profitable Insider Trade
The most profitable trade made by David Michael Johnson
David Michael Johnson's Trading History
Zentalis Pharmaceuticals
Nov 13, 2023
Director
Informative Buy
167.79K
$1.78M
Aura Biosciences Inc
Nov 09, 2023
Director
Informative Buy
1.43M
$3.19M
List of latest transactions for each holding click on a transaction to see David Michael Johnson's performance on stock
You May Also Like
David Michael Johnson insider profile FAQ
What is the percentage of profitable transactions made by David Michael Johnson?
The percentage of profitable transactions made by David Michael Johnson is 29%.
What is the average return per transaction made by David Michael Johnson?
The average return per transaction made by David Michael Johnson is -6.20%.
What stocks does David Michael Johnson hold?
David Michael Johnson holds: ZNTL, AURA stocks.
What was David Michael Johnson’s latest transaction?
David Michael Johnson latest transaction was an Informative Buy of $167.79K.
What was David Michael Johnson's most profitable transaction?
David Michael Johnson’s most profitable transaction was an Informative Buy of ZNTL stock on November 13, 2023. The return on the trade was 14.10%.
What is David Michael Johnson's role in Zentalis Pharmaceuticals?
David Michael Johnson's role in Zentalis Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.